Takeda Pharmaceutical Income Statement (2017-2026)

Reported Financials

Takeda Pharmaceutical Quarterly Income Statement

Periods 32 quarters

Latest Jun 2026

Takeda Pharmaceutical reported revenue of $7.65B and net income of $1.33B for the quarter ended Jun 2026, up 0.1% year over year. This income statement covers 32 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement	Mar2021	Jun2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue	7.28B	8.67B	8.37B	7.52B	7.26B	7.76B	8.00B	7.72B	22.25B	7.11B	8.15B	7.76B	23.65B	6.93B	7.92B	7.65B	23.95B	7.11B	7.78B	7.65B
Cost of RevenueCost of Rev	2.39B	2.20B	2.52B	2.26B	2.21B	2.38B	2.43B	2.34B	7.23B	2.59B	2.61B	2.49B	8.03B	2.52B	2.54B	2.66B	8.13B	2.64B	2.59B	2.55B
Gross Profit	4.88B	6.47B	5.85B	5.39B	15.47B	4.58B	5.58B	5.10B	15.02B	4.52B	5.54B	5.02B	15.62B	4.42B	5.38B	5.40B	15.81B	4.48B	5.19B	5.10B
Operating items
Amortization - Intangibles
Operating Interest ExpensesOp. Interest Exp.
Research & DevelopmentR&D	-1.07B	-1.12B	-1.24B	-1.11B	-1.12B	-1.24B	-1.23B	-1.19B	-1.27B	-1.27B	-1.32B	-1.08B	-1.18B	-1.12B	-1.42B	-0.99B	-1.10B	-1.14B	-1.25B	-1.05B
Selling, General & AdministrativeSG&A	-2.21B	-2.01B	-1.99B	-1.79B	-1.80B	-1.86B	-1.88B	-1.81B	-1.75B	-1.81B	-1.92B	-1.73B	-1.80B	-1.78B	-1.94B	-1.77B	-1.72B	-1.84B	-1.86B	-1.80B
Restructuring CostsRestructuring
Other Operating ExpensesOther Opex	-0.98B	-0.24B	-0.24B	-0.22B	-0.40B	-0.31B	-0.25B	-0.24B	-1.01B	-0.42B	-0.43B	-0.41B	-1.11B	-0.41B	-0.42B	-0.19B	-1.12B	-3.02B	-0.35B	-0.35B
Operating ExpensesOpex	-3.28B	-3.13B	-3.23B	-1.92B	-5.38B	-1.80B	-1.88B	-1.85B	-5.32B	-1.93B	-1.82B	-1.72B	-5.42B	-1.95B	-1.77B	-1.85B	-5.49B	-1.92B	-1.83B	-2.85B
Operating IncomeOp. Inc	2.35B	2.27B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.28B	2.87B	-2.70B	1.28B	1.26B
EBIT	2.35B	2.27B	2.14B	1.16B	0.76B	1.04B	1.27B	1.23B	2.78B	0.60B	1.14B	1.07B	2.80B	-0.49B	1.21B	1.28B	2.87B	-2.70B	1.28B	1.26B
Non-operating items
Non Operating Interest Expenses	-0.71B	-0.65B		-0.43B	-0.39B	-0.56B	-0.45B	-0.43B	-1.20B	-0.33B	-0.40B	-0.38B	-1.16B	-0.33B	-0.70B	-0.74B	-2.13B	-0.35B	-0.68B	-0.40B
Goodwill impairment chargesGoodwill Impair.
Non Operating Investment IncomeNon-Op. Investment Inc.
Interest & Investment IncomeInt & Inv Inc	0.45B	0.42B		0.47B	0.11B	0.30B	0.46B	0.19B	0.38B	0.09B	0.21B	0.20B	0.31B	0.12B	0.48B	0.51B	1.40B	0.12B	0.47B	0.15B
Other Non Operating IncomeOther Non Op Inc.
Non Operating IncomeNon Op. Inc.
Net income details
EBT	2.11B	2.04B	1.92B	1.20B	0.47B	0.76B	1.18B	0.99B	2.27B	0.32B	0.92B	0.88B	1.89B	-0.71B	0.99B	1.04B	2.12B	-2.96B	1.04B	1.02B
Tax ProvisionsTaxes	1.87B	-0.78B	-0.73B	-0.39B	-0.02B	0.08B	-0.38B	-0.33B	0.32B	0.30B	-0.31B	-0.27B	-0.48B	0.29B	-0.27B	-0.18B	-0.65B	0.56B	-0.32B	-0.31B
Profit After TaxPAT	0.24B	2.82B	2.65B	1.59B	0.49B	0.67B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.22B	2.78B	-3.52B	1.35B	1.33B
Equity Income	-0.07B	-0.00B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.02B	-0.04B	-0.00B	-0.00B	-0.02B	0.02B	-0.00B	-0.00B	-0.02B	-0.01B	-0.00B	0.00B
Income from Non-Controlling InterestsInc. Minority	0.00B	0.00B		0.00B	-0.00B	0.00B		0.00B	-0.00B		-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B	-0.00B	-0.00B	-0.00B	0.00B
Income from Continuing OperationsIncome (Continuing)	1.89B	2.82B	2.65B	1.59B	0.49B	0.84B	1.56B	1.32B	1.94B	0.02B	1.23B	1.14B	2.37B	-1.00B	1.26B	1.22B	2.78B	-3.52B	1.35B	1.33B
Consolidated Net IncomeConsol Net Inc.	1.89B	1.26B	1.18B	0.81B	0.45B	0.84B	0.79B	0.65B	1.98B	0.21B	0.64B	0.61B	1.42B	-0.68B	0.81B	0.86B	1.47B	-2.39B	0.79B	0.71B
Income towards Parent CompanyParent Net Inc	1.86B	1.26B	1.18B	0.81B	2.07B	0.84B	0.79B	0.65B	1.98B	0.72B	0.64B	0.61B	1.42B	0.16B	0.81B	0.86B	1.47B	0.67B	0.79B	0.71B
Net Income towards Common StockholdersNet Income	1.86B	1.26B	1.18B	0.81B	2.07B	0.84B	0.79B	0.65B	1.98B	0.72B	0.64B	0.61B	1.42B	0.16B	0.81B	0.86B	1.47B	0.67B	0.79B	0.71B
Additional items
EPS (Basic)	13.11	8.86	8.34	5.71	14.56	5.93	5.63	4.62	14.03	5.07	4.52	4.30	9.96	1.10	5.68	5.98	10.23	4.69	5.54	4.96
EPS (Diluted)	13.02	8.79	8.26	5.66	14.44	5.88	5.56	4.57	13.87	5.01	4.48	4.26	9.86	1.09	5.58	5.88	10.06	4.61	5.54	4.96
Shares Outstanding	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B
Shares Outstanding (Diluted)Shares Outstanding (Dil.)	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.14B	0.15B	0.15B	0.15B	0.15B	0.14B	0.14B
Shares Outstanding (Entity)Shares Outstanding (Entity.)	0.14B		0.14B				0.14B				0.14B				0.14B				0.14B
EBITDA	3.67B	3.58B		2.39B	4.70B	2.29B	2.63B	2.48B	7.46B	1.86B	2.61B	2.30B	7.33B	0.74B	2.64B	2.53B	7.29B	-1.47B	2.51B	2.29B
Interest ExpensesInt Expense	-0.71B	-0.65B		-0.43B	-0.39B	-0.56B	-0.45B	-0.43B	-1.20B	-0.33B	-0.40B	-0.38B	-1.16B	-0.33B	-0.70B	-0.74B	-2.13B	-0.35B	-0.68B	-0.40B
Tax Rate	88.71%					11.20%			14.33%	92.90%

Takeda Pharmaceutical Income Statement API

Pull Takeda Pharmaceutical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TAK&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "TAK", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=TAK&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Takeda Pharmaceutical TAK Income Statement (2017-2026)

Takeda Pharmaceutical Quarterly Income Statement

Takeda Pharmaceutical Income Statement API

Create an account

Sign In

Reset Password